Increased plasma adrenomedullin in acute myocardial infarction.
Adrenomedullin has a potent vasodilating effect comparable to that of calcitonin gene-related peptide. To investigate the pathophysiologic role of endogenous adrenomedullin, we determined sequentially the plasma adrenomedullin level in 15 consecutive patients with acute myocardial infarction (AMI). Plasma adrenomedullin was higher immediately after the onset of AMI and decreased gradually; plasma levels during the 3-week period after the AMI were higher than plasma levels in 15 healthy control subjects (p < 0.001), with higher levels in patients with congestive heart failure than in patients without congestive heart failure throughout the period of the study (p < 0.05). Plasma adrenomedullin was positively correlated with pulmonary capillary wedge pressure, pulmonary arterial pressure, right atrial pressure, and heart rate in the early stage of AMI. These findings suggest that the elevation of plasma adrenomedullin is related to the retention of body fluid volume, the enhancement of sympathetic activity, and/or the elevation of pressure in pulmonary vascular beds. Adrenomedullin may act against excessive vasoconstrictors increased in AMI.
Kobayashi
K
K
First Department of Internal Medicine, Miyazaki Medical College, Japan.
Kitamura
K
K
Hirayama
N
N
Date
H
H
Kashiwagi
T
T
Ikushima
I
I
Hanada
Y
Y
Nagatomo
Y
Y
Takenaga
M
M
Ishikawa
T
T
Imamura
T
T
Koiwaya
Y
Y
Eto
T
T
D053607:Adrenomedullin; D000368:Aged; D016022:Case-Control Studies; D005260:Female; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood* / Q000503:physiopathology; D010455:Peptides / Q000097:blood*; D013997:Time Factors; D014665:Vasodilator Agents / Q000097:blood*
D010455:Peptides; D014665:Vasodilator Agents; D053607:Adrenomedullin